Atlas Trials

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Clinical trial NCT02384941 · COMPLETED

Trial details

NCT number
NCT02384941
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2015-03-01
Primary completion
2016-09-01
Enrollment
793

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.